GLP-1, Kidney Disease and Dr Shuyao Zhang
New diabetes drugs could reduce kidney disease death risk
These drugs, called GLP1-RAs (short for glucagon-like peptide-1 receptor agonists), have been found to reduce hospital visits, slow kidney disease progression, and lower the risk of death for patients with both diabetes and kidney disease.
Treating a kidney infection involves consulting with a doctor for antibiotics, staying hydrated, and managing pain.
4don MSN
A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...
A questionnaire was developed and mailed in March 1999 to 270 adult kidney transplant recipients ... patient's source of funding for immunosuppressive medications, such as prednisone and ...
Some symptoms are felt at night which most people ignore, but these symptoms can be signs that your kidney is slowly getting ...
More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback